Showing all entries tagged with »orphan«

March 12, 2019

Are Solutions for Rare Diseases in Jeopardy?

This blog was originally published in French, in Les Echos newspaper. How can we align the progress of medicine with the patients’ needs? How can we ensure that new life-saving medicines continue to be produced? How can Europe keep its… read more

---

December 6, 2018

Changes in sight for OMPs and biosimilars in Germany?

The German Ministry of Health recently released a draft bill proposal that would introduce significant changes to the legislation on Orphan Medicinal Products (OMPs) and biosimilars in Germany. The bill, which has yet to pass the Cabinet for approval, sets… read more

---